仿制良性前列腺增生药物价格存在极端差异
该研究通过电话调查机构周边25英里内所有药房,获取坦索罗辛、非那雄胺及奥昔布宁30天自付价格。结果显示255家药房应答率93%,最常见BPH药物中位自付价格差异高达5.5倍,且人口学和社会经济因素与价格变异无显著关联。
要点
- 同一区域内仿制BPH药物自付价格最高差5.5倍
- 药房类型(连锁、批发、独立)间价格差异明显
- 人口学和社会经济因素与价格变异无显著关联
核心结论
- 在地理局限区域内,仿制BPH药物的自付价格在不同药房间存在显著差异。
研究设计与样本
- 研究识别机构25英里半径内所有药房并分类为连锁、批发或独立药房。
- 通过脚本化电话调查获取坦索罗辛0.4mg、非那雄胺5mg、奥昔布宁5mg每日三次及奥昔布宁10mg缓释剂30天自付价格。
- 采用多变量线性回归评估人口普查区人口学和社会经济因素与仿制药物自付价格差异的关联。
主要发现
- 应答率为93%,共255家药房覆盖173个人口普查区提供数据。
- 按药房类型,最常见BPH药物中位自付价格差异高达5.5倍。
- 人口学和社会经济因素与仿制BPH药物价格变异无显著关联。
临床怎么用
- 临床医生应了解仿制BPH药物价格在不同药房间存在显著差异,可引导患者比价。
- 研究提示需开展质量改进项目,赋能患者进行价格比较并提高药品价格透明度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize geographic variability of generic benign prostatic hyperplasia (BPH) medications in order to improve drug price transparency and improve patient access to affordable medication sources. This is of interest because BPH is one of the most common chronic diseases in men and contributes to individual healthcare cost. Medical therapy is the main treatment modality for BPH, burdening patients with lifelong medication expenses which may impact adherence and subsequent outcomes. With an aging population, this is compounded by many older individuals requiring multiple daily medications. METHODS: All pharmacies within a 25-mile radius of our institution were identified and classified as chain, wholesale or independent. The out-of-pocket price for a 30-day supply of tamsulosin (0.4 mg), finasteride (5 mg), oxybutynin (5 mg TID), and oxybutynin 10 mg XL were obtained using a scripted telephone survey. Multivariable linear regression assessed the association between census-tract level demographic and socioeconomic factors and disparate generic out-of-pocket drug-pricing. RESULTS: The response rate was 93% with 255 pharmacies across 173 census tracts providing data. By pharmacy type, there was up to 5.5-fold variation in median out-of-pocket drug prices for the most common BPH medications. Demographic and socioeconomic factors were not significantly associated with generic BPH drug price variation. CONCLUSION: The out-of-pocket price of generic medications for BPH varies significantly between pharmacies in a geographically-confined area. This study highlights the need for quality improvement initiatives that empower patients to price-compare and improve drug price transparency.
引用
- Theisen KM, Park SY, Jeong K, et al. Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications. Urology. 2018. PMID: 30359708. doi:10.1016/j.urology.2018.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。